Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Roche’s Enspryng nets a second indication on FDA eye disease approval | PharmaVoice

Pharma Tech

Roche’s Enspryng nets a second indication on FDA eye disease approval

Oct 19, 2026, 4:28 PM

Read Full Article → Roche’s Enspryng nets a second indication on FDA eye disease approval

Roche’s Enspryng nets a second indication on FDA eye disease approval

Translate article text

Choose a language and wait for the translated text.

Enspryng is the first drug suitable for at-home administration in TED, but analysts are lukewarm on its commercial potential.